Using tissue-based fibrosis biomarkers in determining unfavorable AILD outcomes: the role of qFibrosis
Leticia Khendek1, Cyd Castro-Rojas1, Nelson Constance1, Mosab Alquraish1, Rebekah Karns1,2, Jennifer Kasten1,2, Alvin Leong3, Alexander Miethke1,2, Amy E Taylor1,2.
1Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States; 2Department of Pediatrics, University of Cincinnati , Cincinnati, OH, United States; 3HistoIndex Pte Ltd, Singapore, Singapore
Introduction: Children with Autoimmune Liver Disease (AILD) may develop fibrosis-related complications necessitating liver transplant. We hypothesize that tissue-based analysis of liver fibrosis by Second Harmonic Generation (SHG) microscopy with Artificial Intelligence (AI) analysis can yield prognostic biomarkers in AILD.
Methods: Patients from single-center prospective studies with unstained slides from clinically-obtained liver biopsy at AILD diagnosis were identified. Baseline demographics and liver biochemistries were collected at diagnosis and 1 year. In collaboration with HistoIndex®, unstained slides underwent SHG/AI analysis to map fibrosis according to 9 quantitative fibrosis (qFibrosis) parameters.
Results: Sixty-four patients with AIH (50%), PSC (33%) or ASC (17%) at a median of 14 years old (range 3-24 years) were included. Four patients were listed for liver transplant within 36 months from diagnosis. An unsupervised analysis of qFibrosis parameters identified two distinct patient clusters: one with more females, PSC/ASC, and IBD. This group had more fibrosis by METAVIR classification (3 vs 2; p=0.0008) and persistently abnormal ALT at 12 months (42.4% vs 13.3%; p=0.01). qFibrosis parameters were most predictive of abnormal 12-month ALT. Perisinusoidal and overall fibrosis were most associated with abnormal 12-month biochemistries. In the multiple regression model, sex had an OR of 5.4 (p=0.02) and NumStr of 10.9 (p=0.0007) of abnormal 12-month ALT (AUC 0.82).
Conclusions: The application of SHG/AI algorithms in pediatric-onset AILD improves the predictive performance of liver histopathology. SHG allows to identify patients more at risk of severe liver disease as well as fibrosis patterns related to persistently abnormal biochemistries at one year from diagnosis.
If you have any questions during the meeting, please go to the registration desk. Our emails will be monitored sporadically.
REGISTRATION DESK OPENING TIMES
Sunday, October 15, 16:00-18:00 Monday, October 16, 07:00-18:00 Tuesday October 17, 07:00-12:30